Tito R. Mendoza

Patient-Centered Outcomes Research Institute

Also affiliated with Office of the Director, National Cancer Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.165Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Assessing sleep in primary brain tumor patients using smart wearables and patient-reported data: Feasibility and interim analysis of an observational study

Neuro-Oncology Practice(2024)10.1093/nop/npae048

Top 70%

0.165DataRank

Top 70%2 citations

Alex Wollet, Julianie De La Cruz Minyety, Elizabeth Vera, Hope Miller, Orieta Celiku +24 more

Papers

Driven by 38 papers — median percentile 0. Top paper: “Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience”.

Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience

The Oncologist(2023)10.1093/oncolo/oyad118

N/A

0.768DataRank · unranked

26 citations

Felipe Soto, Linda Zhong, Fechukwu Akhmedzhanov, Nathaniel R. Wilson, Abdulrazzak Zarifa +23 more

A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma

Neuro-Oncology(2020)10.1093/neuonc/noaa240

N/A

0.621DataRank · unranked

62 citations

Ying Yuan, Jimin Wu, Tito R. Mendoza, Elizabeth Vera, Antonio Omuro +9 more

Financial Hardship in Survivorship Care Delivery

JNCI Monographs(2020)10.1093/jncimonographs/lgaa012

N/A

0.500DataRank · unranked

27 citations

Tito R. Mendoza, Lisa M. Lowenstein, Ya‐Chen Tina Shih, Grace L. Smith

Short-form adaptive measure of financial toxicity from the Economic Strain and Resilience in Cancer (ENRICh) study: Derivation using modern psychometric techniques

PLoS ONE(2022)10.1371/journal.pone.0272804

N/A

0.457DataRank · unranked

20 citations

Grace L. Smith, Ying‐Shiuan Chen, Cristina M. Checka, Sharon H. Giordano, Kelsey Kaiser +10 more

Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial

Scientific Reports(2022)10.1038/s41598-022-16588-3

N/A

0.375DataRank · unranked

4 citations

David S. Hong, Christine B. Peterson, Bettzy Stephen, Ecaterina E. Dumbrava, Shubbam Pant +18 more

Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT)

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac029

N/A

0.292DataRank · unranked

6 citations

Emily S. Tonorezos, Deborah K. Mayer, Marie Bakitas, Susan M. Chang, Mary E. Cooley +75 more

Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trial

BMC Cancer(2023)10.1186/s12885-023-10671-2

N/A

0.283DataRank · unranked

4 citations

Alvina Acquaye-Mallory, Elizabeth Vera, Tito R. Mendoza, Jennifer Reyes, Macy Stockdill +3 more

Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden

Cancers(2025)10.3390/cancers17213459

N/A

0.269DataRank · unranked

5 citations

Sandra A. Mitchell, Ethan Basch, Allison M. Deal, Blake Langlais, Gita Thanarajasingam +8 more

Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE ® ) in a diverse cancer sample

Clinical Trials(2024)10.1177/17407745241286065

N/A

0.208DataRank · unranked

3 citations

Ethan Basch, Lauren Rogak, Blake Langlais, Gita Thanarajasingam, Brenda Ginos +10 more

Assessing sleep in primary brain tumor patients using smart wearables and patient-reported data: Feasibility and interim analysis of an observational study

Neuro-Oncology Practice(2024)10.1093/nop/npae048

Top 70%

0.165DataRank

Top 70%2 citations

Alex Wollet, Julianie De La Cruz Minyety, Elizabeth Vera, Hope Miller, Orieta Celiku +24 more

Phase II trial evaluating nivolumab in patients with recurrent IDH-mutant gliomas with and without hypermutation phenotype.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e14043

N/A

0.165DataRank · unranked

2 citations

Ying Yuan, Kelly Mentges, Jennifer Reyes, Tito R. Mendoza, Terri S. Armstrong +13 more

Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clustering

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac188

N/A

0DataRank · unranked

10 citations

Elizabeth Vera, Gal Ophir, Alexa Christ, Amanda King, Alvina Acquaye +15 more

A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian, and colorectal cancer susceptibility genes.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10512

N/A

0DataRank · unranked

3 citations

Brooke Levin, Megan Ensinger, Kristin Mattie, Robert J. Volk, Zhongming Zhao +9 more

Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-0855

N/A

0DataRank · unranked

23 citations

Wei Zhang, Seth M. Steinberg, Darryl Nousome, Nicole Houston, Xiaolin Wu +22 more

Development and validation of a patient‐reported outcome measure to assess symptom burden after chimeric antigen receptor T‐cell therapy

British Journal of Haematology(2023)10.1111/bjh.18677

N/A

0DataRank · unranked

18 citations

Samer A. Srour, Tito R. Mendoza, Meagan Whisenant, Ishwaria M. Subbiah, Elizabeth M. Gonzalez +9 more

Should We Use COMM (Current Opioid Misuse Measure) to Screen for Opioid Abuse in Patients With Cancer Pain?

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7054

N/A

0DataRank · unranked

8 citations

Tito R. Mendoza, Susan D. Horn, Jelyn C. Eustaquio, Charles S. Cleeland, Charles E. Inturrisi +1 more

Pilot study of a Spanish language measure of financial toxicity in underserved Hispanic cancer patients with low English proficiency

Frontiers in Psychology(2023)10.3389/fpsyg.2023.1188783

N/A

0DataRank · unranked

6 citations

Gwendolyn J. McGinnis, Susan K. Peterson, Nicolette Taku, Ying‐Shiuan Chen, Robert Yu +11 more

Identification of health-related quality of life profiles among long-term survivors of primary central nervous system tumors

Journal of Neuro-Oncology(2023)10.1007/s11060-023-04474-5

N/A

0DataRank · unranked

3 citations

Tito R. Mendoza, Terri S. Armstrong, Christine Miaskowski, Bruce A. Cooper, Elizabeth Vera +1 more

Assessing gaps in motherhood after cancer: development and psychometric testing of the Survivorship Oncofertility Barriers Scale

International Journal of Gynecological Cancer(2023)10.1136/ijgc-2023-004302

N/A

0DataRank · unranked

2 citations

Chloe Josephine Denham, Shuangshuang Fu, Tito R. Mendoza, Roni Nitecki, Kirsten Jorgensen +5 more

Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

(2023)10.1158/1078-0432.c.6530789

Top 100%

0DataRank

Top 100%0 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

(2023)10.1158/1078-0432.c.6530789.v1

Top 100%

0DataRank

Top 100%0 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Baseline symptom, health status, and health utilities in patients in early-phase clinical trials combining immune checkpoint blockade with other anticancer therapies.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12117

N/A

0DataRank · unranked

0 citations

Sarina A. Piha‐Paul, Siqing Fu, Jordi Rodon Ahnert, Timothy A. Yap, Vivek Subbiah +10 more

Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma

Scientific Reports(2024)10.1038/s41598-024-62307-5

N/A

0DataRank · unranked

10 citations

Karen Keating, Brian J. Cuffel, Cem Elbi, Jonathan Siegel, Christoph Gerlinger +8 more

Outcomes for breast cancer survivors with metastatic disease in a physical activity program for medically underserved cancer survivors

Journal of Cancer Survivorship(2024)10.1007/s11764-024-01600-8

N/A

0DataRank · unranked

5 citations

Kylee Laffoon, Scherezade K. Mama, Yue Liao, Meagan Whisenant, Abenaa M. Brewster +6 more

Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report

Neuro-Oncology(2025)10.1093/neuonc/noaf118

N/A

0DataRank · unranked

8 citations

Michael A. Vogelbaum, Timothy F. Cloughesy, Norbert Galldiks, Nathalie L. Albert, Joerg-Christian Tonn +30 more

ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History Study

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf002

N/A

0DataRank · unranked

2 citations

McKenzie C. Kauss, Dhaivat Raval, Emory Hsieh, Ann Choi, Tara S. Davis +10 more

Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report

The Lancet Oncology(2020)10.1016/s1470-2045(19)30796-x

N/A

0DataRank · unranked

81 citations

Linda Dirven, David Arons, Amanda Bates, Susan M. Chang, Corneel Coens +12 more

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative

Neuro-Oncology(2025)10.1093/neuonc/noaf108

N/A

0DataRank · unranked

0 citations

Linda Dirven, Tobias Walbert, Terri S. Armstrong, David Arons, Martin J. van den Bent +24 more

Reliability of self-reported smoking history and its implications for lung cancer screening

Preventive Medicine Reports(2020)10.1016/j.pmedr.2019.101037

N/A

0DataRank · unranked

46 citations

Tito R. Mendoza, Diana S. Hoover, Shawn Nishi, Noah J. Choi, Therese B. Bevers +1 more

The prevalence of altered body image in patients with primary brain tumors: an understudied population

Journal of Neuro-Oncology(2020)10.1007/s11060-020-03433-8

N/A

0DataRank · unranked

11 citations

Elizabeth Vera, Alvina Acquaye, Sonja Crandon, Veeraj Shah, Christine Bryla +18 more

Percutaneous Cordotomy for Pain Palliation in Advanced Cancer: A Randomized Clinical Trial Study Protocol

Neurosurgery(2020)10.1093/neuros/nyz527

N/A

0DataRank · unranked

8 citations

Aditya Vedantam, Loretta A. Williams, Dhanalakshmi Koyyalagunta, Salahadin Abdi, Patrick M. Dougherty +5 more

Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module

Japanese Journal of Clinical Oncology(2020)10.1093/jjco/hyaa036

N/A

0DataRank · unranked

6 citations

Iori Sato, Masamichi Takahashi, Terri S. Armstrong, Charles S. Cleeland, Tito R. Mendoza +6 more

Composite grading algorithm for National Cancer Institute’s PRO-CTCAE.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7018

N/A

0DataRank · unranked

5 citations

Claus Becker, Lauren J. Rogak, Deborah Schrag, Bryce B. Reeve, Patricia A. Spears +15 more

Shared Decision-Making for Lung Cancer Screening

CHEST Journal(2021)10.1016/j.chest.2021.01.041

N/A

0DataRank · unranked

64 citations

Lisa M. Lowenstein, Tito R. Mendoza, María A. López-Olivo, Laura Crocker, Karen Sepucha +3 more

Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.07.007

N/A

0DataRank · unranked

61 citations

Samer A. Srour, Meagan Whisenant, Ishwaria M. Subbiah, Tsun Hsuan Chen, Darcy Ponce +10 more

Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4730

N/A

0DataRank · unranked

60 citations

Ying Yuan, Debra A. Long Priel, Danielle Fink, Cody J. Peer, Tristan M. Sissung +30 more

Associations between the gut microbiome and fatigue in cancer patients

Scientific Reports(2021)10.1038/s41598-021-84783-9

N/A

0DataRank · unranked

45 citations

Tito R. Mendoza, Liangliang Zhang, Siqing Fu, Sarina A. Piha‐Paul, David S. Hong +10 more

Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial

Supportive Care in Cancer(2021)10.1007/s00520-021-06110-2

N/A

0DataRank · unranked

5 citations

Qiuling Shi, Tito R. Mendoza, Araceli García-González, Ting‐Yu Chen, Mona Kamal +5 more

Tito R. Mendoza

Indexed papers

Top data-sharing exemplar

Papers